Fatostatin promotes anti-tumor immunity by reducing SREBP2 mediated cholesterol metabolism in tumor-infiltrating T lymphocytes
Article in European Journal of Pharmacology (March 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in European Journal of Pharmacology (March 2024)
Article in JCI Insight (March 2024)
Preprint in bioRxiv (March 2024)